GK

Gurjala Kirupanandam

Active Director Director DIN 05193994
DIN 05193994 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2012
Shareholding value •••• Premium profile

About Gurjala Kirupanandam

Data last updated:

Gurjala Kirupanandam is a Director at Latin Labs Private Limited (since 2012) and Director at Stcc Medicare Private Limited (since 2017). The companies operate in Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹5.14 Cr; the largest is Latin Labs Private Limited at ₹5.00 Cr (FY 2024).

DIN 05193994
Primary Designation Director
Industry Pharma
First Appointment 16 May 2012
Oldest Company Age 14 yrs
Largest company Latin Labs Private Limited · ₹5.00 Cr (FY 2024)
Combined revenue ₹5.14 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Latin Labs Private Limited U85100TN2012PTC085924
Director16 May 20122012₹5.00 Cr (FY 2024)Active
Stcc Medicare Private Limited U74999TN2017PTC114203
Director19 Jan 20172017₹14.1 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
Stcc Medicare Private Limited
Latin Labs Private Limited
Premium access

Shareholding and investment profile for Gurjala Kirupanandam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurjala Kirupanandam

Gurjala Kirupanandam currently holds 2 directorships: Latin Labs Private Limited (Director, since 16 May 2012, revenue ₹5.00 Cr (FY 2024)); Stcc Medicare Private Limited (Director, since 19 Jan 2017, revenue ₹14.1 Lakh (FY 2022)).

Gurjala Kirupanandam was first appointed on 16 May 2012 as Director at Latin Labs Private Limited. The most recent appointment on record is 19 Jan 2017 at Stcc Medicare Private Limited.

The 2 current companies of Gurjala Kirupanandam that report revenue have a combined latest revenue of ₹5.14 Cr: Latin Labs Private Limited ₹5.00 Cr (FY 2024); Stcc Medicare Private Limited ₹14.1 Lakh (FY 2022).

The current boards of Gurjala Kirupanandam's companies include Anandha Krishnan Venkatraman (Latin Labs Private Limited), Anbarasan Puvimathi (Latin Labs Private Limited), Bhuvaneswari (Latin Labs Private Limited), Dhamodharan (Latin Labs Private Limited), Dhanasekar (Latin Labs Private Limited), Ganapathy Rajaraman (Latin Labs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available